The number of people with liver cancer will nearly double worldwide by 2050 unless more is done to address preventable causes ...

Madrigal Pharmaceuticals said on Wednesday it has entered into a licensing agreement worth up to $2 billion with China's CSPC Pharmaceutical Group to develop an oral GLP-1 drug for a serious form of ...